Literature DB >> 10386613

The effects of the selective ROCK inhibitor, Y27632, on ET-1-induced hypertrophic response in neonatal rat cardiac myocytes--possible involvement of Rho/ROCK pathway in cardiac muscle cell hypertrophy.

K Kuwahara1, Y Saito, O Nakagawa, I Kishimoto, M Harada, E Ogawa, Y Miyamoto, I Hamanaka, N Kajiyama, N Takahashi, T Izumi, R Kawakami, N Tamura, Y Ogawa, K Nakao.   

Abstract

A small GTPase, Rho, participates in agonist-induced cytoskeletal organization and gene expression in many cell types including cardiac myocytes. However, little is known about the functions of Rho's downstream targets in cardiac myocytes. We examined the role of ROCK, a downstream target of Rho, in ET-1-induced hypertrophic response. Y27632, a selective ROCK inhibitor, inhibited ET-1-induced increases in natriuretic peptide production, cell size, protein synthesis, and myofibrillar organization. In addition, a dominant-negative mutant of p160ROCK suppressed ET-1-induced transcription of the BNP gene. These findings suggest that the Rho/ROCK pathway is an important component of ET-1-induced hypertrophic signals in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386613     DOI: 10.1016/s0014-5793(99)00680-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts.

Authors:  Geraldine Pawlak; David M Helfman
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

2.  Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA.

Authors:  F Charron; G Tsimiklis; M Arcand; L Robitaille; Q Liang; J D Molkentin; S Meloche; M Nemer
Journal:  Genes Dev       Date:  2001-10-15       Impact factor: 11.361

Review 3.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 4.  Rho kinase as a therapeutic target in cardiovascular disease.

Authors:  Michelle Surma; Lei Wei; Jianjian Shi
Journal:  Future Cardiol       Date:  2011-09

5.  Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.

Authors:  Li Chu; Ikuo Norota; Masao Endoh
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04-20       Impact factor: 3.000

6.  Myocardin-related transcription factor A is a common mediator of mechanical stress- and neurohumoral stimulation-induced cardiac hypertrophic signaling leading to activation of brain natriuretic peptide gene expression.

Authors:  Koichiro Kuwahara; Hideyuki Kinoshita; Yoshihiro Kuwabara; Yasuaki Nakagawa; Satoru Usami; Takeya Minami; Yuko Yamada; Masataka Fujiwara; Kazuwa Nakao
Journal:  Mol Cell Biol       Date:  2010-07-06       Impact factor: 4.272

7.  Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase.

Authors:  Zhekang Ying; Peibin Yue; Xiaohua Xu; Mianhua Zhong; Qinghua Sun; Michael Mikolaj; Aixia Wang; Robert D Brook; Lung Chi Chen; Sanjay Rajagopalan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

8.  Disruption of ROCK1 gene attenuates cardiac dilation and improves contractile function in pathological cardiac hypertrophy.

Authors:  Jianjian Shi; Yi-Wei Zhang; Lelia J Summers; Gerald W Dorn; Lei Wei
Journal:  J Mol Cell Cardiol       Date:  2007-12-08       Impact factor: 5.000

9.  Real-time monitoring of hypertrophy in HL-1 cardiomyocytes by impedance measurements reveals different modes of growth.

Authors:  Laura Bloch; Bernadin Ndongson-Dongmo; Angelika Kusch; Duska Dragun; Regine Heller; Otmar Huber
Journal:  Cytotechnology       Date:  2016-07-05       Impact factor: 2.058

10.  Wnt signaling promotes AChR aggregation at the neuromuscular synapse in collaboration with agrin.

Authors:  Juan P Henriquez; Anna Webb; Matthew Bence; Heidi Bildsoe; Macarena Sahores; Simon M Hughes; Patricia C Salinas
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.